THE Food and Drug Administration (FDA) is working closely with the Bureau of Internal Revenue (BIR) to make some essential medicines more affordable for senior citizens.
FDA Director General Samuel Zacate said the two agencies were now determining how to exempt certain medicines from the value-added tax (VAT) that would be consistent with the Corporate Recovery and Tax Incentives for Enterprises (Create) Act.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.